Total Payments
$10,519
2024 Payments
$1,101
Companies
26
Transactions
368
Medicare Patients
2,955
Medicare Billing
$371,031
Payment Breakdown by Category
Food & Beverage$10,502 (99.8%)
Education$16.34 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,502 | 366 | 99.8% |
| Education | $16.34 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,178 | 96 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,030 | 54 | $0 (2024) |
| Merck Sharp & Dohme LLC | $872.04 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $685.58 | 34 | $0 (2024) |
| Gilead Sciences, Inc. | $637.39 | 15 | $0 (2019) |
| PFIZER INC. | $563.74 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $528.31 | 25 | $0 (2024) |
| Boston Scientific Corporation | $298.57 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $225.67 | 13 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $215.00 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,101 | 42 | Janssen Pharmaceuticals, Inc ($261.67) |
| 2023 | $1,913 | 69 | Janssen Pharmaceuticals, Inc ($705.20) |
| 2022 | $1,430 | 59 | Janssen Pharmaceuticals, Inc ($601.16) |
| 2021 | $1,472 | 65 | Janssen Pharmaceuticals, Inc ($593.52) |
| 2020 | $574.12 | 26 | Janssen Pharmaceuticals, Inc ($274.79) |
| 2019 | $1,432 | 41 | Janssen Pharmaceuticals, Inc ($760.59) |
| 2018 | $1,360 | 38 | Janssen Pharmaceuticals, Inc ($564.48) |
| 2017 | $1,237 | 28 | Janssen Pharmaceuticals, Inc ($416.32) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/27/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Coronary | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $55.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Not Applicable | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: DIABETES | ||||||
| 08/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: DIABETES | ||||||
| 05/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 703 | 1,103 | $271,577 | $81,017 |
| 2022 | 8 | 798 | 1,256 | $320,175 | $100,820 |
| 2021 | 9 | 719 | 1,232 | $300,553 | $100,680 |
| 2020 | 10 | 735 | 1,203 | $293,117 | $88,514 |
Total Patients
2,955
Total Services
4,794
Medicare Billing
$371,031
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 194 | 422 | $84,400 | $29,532 | 35.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 167 | 168 | $100,800 | $29,057 | 28.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 49 | 49 | $36,015 | $10,407 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $14,210 | $4,379 | 30.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 196 | 364 | $21,112 | $3,926 | 18.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $7,150 | $1,940 | 27.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 26 | 26 | $7,540 | $1,658 | 22.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 14 | $350.00 | $117.60 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 216 | 509 | $101,890 | $37,279 | 36.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 176 | 177 | $106,200 | $31,886 | 30.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 65 | 65 | $47,775 | $14,917 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $16,240 | $4,971 | 30.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 22 | 22 | $14,300 | $4,334 | 30.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 212 | 375 | $21,750 | $4,235 | 19.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 34 | 34 | $9,860 | $2,289 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 18 | $2,160 | $908.14 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 194 | 529 | $105,800 | $41,103 | 38.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 152 | 152 | $91,200 | $29,393 | 32.2% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 65 | 69 | $50,715 | $16,068 | 31.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 48 | 48 | $13,920 | $4,537 | 32.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 180 | 346 | $20,068 | $4,473 | 22.3% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 11 | 11 | $7,150 | $2,238 | 31.3% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 29 | 29 | $8,410 | $1,902 | 22.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 22 | $2,640 | $887.84 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 23 | 26 | $650.00 | $78.00 | 12.0% |
About Hung-Sam Lee
Hung-Sam Lee is a Cardiovascular Disease healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730210949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hung-Sam Lee has received a total of $10,519 in payments from pharmaceutical and medical device companies, with $1,101 received in 2024. These payments were reported across 368 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($10,502).
As a Medicare-enrolled provider, Lee has provided services to 2,955 Medicare beneficiaries, totaling 4,794 services with total Medicare billing of $371,031. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Flushing, NY
- Active Since 03/08/2007
- Last Updated 01/15/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730210949
Products in Payments
- XARELTO (Drug) $3,630
- VERQUVO (Drug) $666.98
- FARXIGA (Drug) $568.76
- INVOKANA (Drug) $547.40
- JARDIANCE (Drug) $497.80
- ELIQUIS (Drug) $475.08
- BRILINTA (Drug) $397.88
- LEQVIO (Drug) $353.92
- Vemlidy (Drug) $266.17
- Vascepa (Drug) $225.67
- WATCHMAN (Device) $213.17
- ENTRESTO (Drug) $174.39
- SAPIEN 3 Ultra RESILIA (Device) $156.01
- OPSUMIT (Drug) $145.53
- PRALUENT (Drug) $132.60
- Livalo (Drug) $125.00
- Ranexa (Drug) $118.58
- PREVNAR - 13 (Biological) $113.64
- PRADAXA (Drug) $111.66
- Ozempic (Drug) $101.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Flushing
Madar Abed, Md, MD
Cardiovascular Disease — Payments: $98,164
Cardiovascular Disease $98,164
Dr. Joseph Ma, Md, MD
Cardiovascular Disease — Payments: $18,815
Cardiovascular Disease $18,815
Dr. Jiong-Ming Hu, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $16,826
Cardiovascular Disease $16,826
Dr. Wai Leung, M.d, M.D
Cardiovascular Disease — Payments: $15,212
Cardiovascular Disease $15,212
Dr. Thomas Chen, M.d, M.D
Cardiovascular Disease — Payments: $12,856
Cardiovascular Disease $12,856
Chong Park, Md, MD
Cardiovascular Disease — Payments: $12,111
Cardiovascular Disease $12,111